|
|
 |
|
Viewing report
|
|
|
|
Generic Strategies in Emerging Markets
Datamonitor, Aug 2009, Pages: 55
The emerging markets are luring a growing number of pharma companies looking to compensate for the diminishing revenues in developed markets. Latin America and Central and Eastern Europe (CEE) are showing strong growth rates, proving to be lucrative targets for firms aiming to expand their foothold, initially as a generics player, but also providing a foundation for subsequent brand penetration.
Scope
- Provides an overview of recent events affecting the generics market in the CEE and Latin America
- Identifies the different barriers and opportunities for growth in the CEE and Latin America
- Provides insight into the growth drivers of multinational and domestic generic players operating in these regions
- Identifies key strategies for entrance and expansion in these markets
Highlights of this title
Sales growth in the CEE generics market is slowing due to increasing competition among generics players, while the Latin American market continues to grow, with significant room for further expansion. Consequently, the Latin American market offers multinationals a better opportunity due to is comparatively greater growth potential.
Indian generics firms are showing a growing interest in the Latin American generics market, especially Brazil. However, going forward, this may undermine the success of domestic players in this region, as Indian generics companies have a ready source of active pharmaceutical ingredients (APIs) and an established low cost manufacturing base.
Generic penetration across the CEE is consistently high due to the historically poor enforcement of intellectual property (IP) laws. However IP issues and competition from similares (non-bioequivalent drugs) hamper penetration of true generics in Latin America, although new regulations have been implemented to target this issue.
Key reasons to purchase this title
- Understand how recent events and trends will affect the generics industry in the CEE and Latin America
- Gain insight into which companies are growing rapidly and which strategies are employed
- Identify the different benefits of entering the CEE and Latin American markets
Customers who bought this item also bought
Emerging Generic Pharmaceuticals Markets in Europe
Telco Investment Strategies in Emerging Markets
Analyzing the Generic Drugs Sector of the US Pharmaceutical Industry
Emerging Pharmaceutical Markets Globally
Agrows Complete Guide to Generic Pesticides: Volume 1, The Companies
The Top 10 Generic Pharmaceutical Companies: Positioning, Performance and SWOT Analyses
Commercial Insight: Asthma & COPD - On the verge of generic entry
Agrows Complete Guide to Generic Pesticides: Volume 2, Products and Markets
Orphan Drug Strategies
Executive Report on Strategies in Ukraine
Executive Report on Strategies in Armenia
Executive Report on Strategies in Austria
|
|
|
|
